# Omnes' Biotech Investments: 12 Startups in Its Portfolio (2026) > The 12 Biotech startups Omnes has backed, by stage: $669M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/omnes-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 5 - [Corteria Pharmaceuticals](https://millionrounds.com/company/corteria-pharmaceuticals) - [DiogenX](https://millionrounds.com/company/diogenx) - [Coave Therapeutics](https://millionrounds.com/company/coave-therapeutics) - [*NT* NH TherAguix](https://millionrounds.com/company/nh-theraguix) - [Antabio](https://millionrounds.com/company/antabio) ## Stage not reported 4 - [ENTEROME](https://millionrounds.com/company/enterome) - [*T* Themis](https://millionrounds.com/company/themis) - [Newronika](https://millionrounds.com/company/newronika) - [OCTIMET Oncology](https://millionrounds.com/company/octimet-oncology) ## Series C and later 3 - [*B* BioVex](https://millionrounds.com/company/biovex) - [*T* TISSIUM](https://millionrounds.com/company/tissium) - [AgomAB Therapeutics](https://millionrounds.com/company/agomab-therapeutics) ## Segment by segment ### Series A 5 startups · $169M raised - [**Corteria Pharmaceuticals**](https://millionrounds.com/company/corteria-pharmaceuticals) Corteria Pharmaceuticals is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2021. France $70M - [**DiogenX**](https://millionrounds.com/company/diogenx) DiogenX is a preclinical-stage biotechnology company founded in 2020, based in Marseille, France, with research laboratories in Nice. France $37M - [**Coave Therapeutics**](https://millionrounds.com/company/coave-therapeutics) Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases. France $33M - [*NT* **NH TherAguix**](https://millionrounds.com/company/nh-theraguix) NH TherAguix is a clinical stage company. France $15M - [**Antabio**](https://millionrounds.com/company/antabio) ANTABIO is a clinical-stage biopharmaceutical company based in Labege, France, focused on developing innovative antibacterial therapies. France $15M ### Stage not reported 4 startups · $124M raised - [**ENTEROME**](https://millionrounds.com/company/enterome) Enterome SA is a clinical-stage biopharmaceutical company based in Paris, France, with operations in Évry. France $58M - [*T* **Themis**](https://millionrounds.com/company/themis) Austria $56M - [**Newronika**](https://millionrounds.com/company/newronika) Newronika restores brain and body functions with innovative technologies. Italy $9.2M - [**OCTIMET Oncology**](https://millionrounds.com/company/octimet-oncology) OCTIMET has licensed from Janssen Pharmaceutica, highly selective MET kinase inhibitors with clean safety profiles - $1.3M ### Series C and later 3 startups · $376M raised - [*B* **BioVex**](https://millionrounds.com/company/biovex) THOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquis United Kingdom $133M - [*T* **TISSIUM**](https://millionrounds.com/company/tissium) France $131M - [**AgomAB Therapeutics**](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. Belgium $112M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Omnes as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Omnes portfolio map** 46 startups · $2.4B](https://millionrounds.com/portfolio-maps/omnes-capital-portfolio-map)[Co-investors **Who invests with Omnes** 27 co-investors](https://millionrounds.com/portfolio-maps/omnes-capital-co-investors)[Sector portfolio **Kima Ventures' AI portfolio** 79 startups · $975M](https://millionrounds.com/portfolio-maps/kima-ventures-ai-portfolio)[Sector portfolio **Sofinnova Partners' Biotech portfolio** 66 startups · $5.9B](https://millionrounds.com/portfolio-maps/sofinnova-partners-biotech-portfolio)[Sector portfolio **Kima Ventures' IT Services portfolio** 55 startups · $233M](https://millionrounds.com/portfolio-maps/kima-ventures-it-services-portfolio)[Sector portfolio **Kima Ventures' Fintech portfolio** 42 startups · $2.6B](https://millionrounds.com/portfolio-maps/kima-ventures-fintech-portfolio) ## Raising from investors like Omnes? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)